US Biotech Market Analysis

RNCOS
December 1, 2011
65 Pages - SKU: CICQ6717525
Countries covered: United States

The US represents the world’s largest biotechnology market, leading with its innovation, extensive R&D, and regular company developments in various spheres of the biotechnology sector. On the back of rising instances of innovations in the information technology, world-class healthcare infrastructure, and active participation by private players, the US biotech industry has grown stupendously in the past few years.

The report, “US Biotech Market Analysis”, covers the Medical Biotechnology, Agricultural Biotechnology, and Industrial Biotechnology segments of the sector. The research finds out which is the largest segment in the biotechnology sector, and why. It also discusses the wider role of the technology.

According to our report, biotech funding has been a major source of growth in the US biotech industry as venture capital and financing by other sources continue to provide the momentum. The structure of financing has been strengthening over the past few years with IPOs, FPOs, public and private sector, and venture funds contributing significantly to the industry developments. Rising focus of companies towards drug development, increasing coverage of various diseases, and significant market potential are some of the prominent factors propelling investments in the recent years.

The report also elaborates the important Bio-clusters prevailing in the US and analyses their growth. It observed that California accounted for the highest growth and attracted maximum funds for research activities. How much employment this cluster generated in the biopharmaceutical sector, has also been covered in the study.

Biotechnology is a priority sector for the government, which has been backing significant developments in the industry. The report identifies key trends in the sector. Of these, bio-similars are found to drive the market positively. It also highlights the competitive landscape in the US biotechnology sector, and lists significant developments of the key players in the segment.

The report finds that the future outlook of the US biotech sector is positive with a substantial amount of investment expected in the research and entrepreneurship development in near future.



More Biotechnology reports by RNCOS

Global Gene Therapy Market Outlook 2018 by RNCOS
Global Gene Therapy Market Outlook 2018 Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or ...
Global Bioinformatics Market Outlook 2019 by RNCOS
Global Bioinformatics Market Outlook 2019 The Bioinformatics market has risen exponentially in recent years into an important segment of the biotechnology industry. The increasing application ...
Global - miRNA Market Outlook to 2018 by RNCOS
Global miRNA Market Outlook to 2018 The recent discovery of miRNA and its wide applicability have sparked off a lot of interest among researchers as ...
Nanotechnology Market Outlook 2020 by RNCOS
Nanotechnology Market Outlook 2020Nanotechnology is a growing interdisciplinary technology often seen as a new industrial revolution. Nanotechnology is increasingly attracting worldwide attention owing to its ...
See all reports like this >>

More United States Biotechnology reports

Genomics Market in the US : 2014-2018 by TechNavio - Infiniti Research Ltd.
Genomics Market in the US 2014-2018About Genomics The genome is the genetic material of an individual, species or organism, which is responsible for the various ...
Biotechnology Product Manufacturing by First Research, Inc.
Biotechnology Product ManufacturingBrief Excerpt from Industry Overview Chapter:Companies in this industry manufacture drugs, therapies, vaccines, genetically modified food and fuel, and other products based on ...
Future Horizons and Growth Strategies in the US Hospital Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts by Venture Planning Group
Future Horizons and Growth Strategies in the US Tumor Marker Testing Market 2014: Supplier Shares and Country Forecasts by Venture Planning Group
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 1,000  
    Hard Copy Mail Delivery  USD 1,100  
    CD-ROM Mail Delivery  USD 1,100  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!